Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $65.80 for the day, up 1.83% from the previous closing price of $64.61. In other words, the price has increased by $1.83 from its previous closing price. On the day, 1.48 million shares were traded. VKTX stock price reached its highest trading level at $65.9889 during the session, while it also had its lowest trading level at $64.42.
Ratios:
Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 37.69 and its Current Ratio is at 37.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on September 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $80.
On June 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.
Raymond James Upgraded its Outperform to Strong Buy on May 16, 2024, whereas the target price for the stock was revised from $115 to $116.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 20 ’24 when SINGLETON J MATTHEW sold 10,300 shares for $69.50 per share. The transaction valued at 715,850 led to the insider holds 9,500 shares of the business.
Lian Brian sold 216,130 shares of VKTX for $15,308,553 on Sep 20 ’24. The President & CEO now owns 2,304,927 shares after completing the transaction at $70.83 per share. On Sep 20 ’24, another insider, Lian Brian, who serves as the Officer of the company, bought 216,130 shares for $18.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 7290377216 and an Enterprise Value of 6349227008.
Stock Price History:
Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is 5.28%, while the 200-Day Moving Average is calculated to be 14.77%.
Shares Statistics:
VKTX traded an average of 3.38M shares per day over the past three months and 2156090 shares per day over the past ten days. A total of 110.80M shares are outstanding, with a floating share count of 103.66M. Insiders hold about 6.44% of the company’s shares, while institutions hold 74.36% stake in the company. Shares short for VKTX as of 1727654400 were 14477819 with a Short Ratio of 4.28, compared to 1724976000 on 17138425. Therefore, it implies a Short% of Shares Outstanding of 14477819 and a Short% of Float of 17.59.
